Average Co-Inventor Count = 3.08
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cv6 Therapeutics (Ni) Limited (17 from 18 patents)
2. Eisai Company, Limited (10 from 677 patents)
3. Eisai R&d Management Co., Ltd. (8 from 530 patents)
4. University of Southern California (4 from 1,635 patents)
5. University of Miami (2 from 377 patents)
6. University System of Maryland (1 from 1,942 patents)
7. Eisai Inc. (1 from 33 patents)
8. Stemsynergy Therapeutics, Inc. (1 from 7 patents)
9. Eisai R&d Co., Ltd. (1 from 1 patent)
10. Cv6 Therapeutics Limited (0 patent)
39 patents:
1. 12275725 - Inhibitors of the notch transcriptional activation complex and methods for use of the same
2. 12098133 - Hydantoin containing deoxyuridine triphosphatase inhibitors
3. 11584723 - Hydantoin containing deoxyuridine triphosphatase inhibitors
4. 11518746 - Nitrogen ring linked deoxyuridine triphosphatase inhibitors
5. 11479531 - Deoxyuridine triphosphatase inhibitors
6. 11198677 - Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
7. 11174271 - 6-membered uracil isosteres
8. 11168059 - Amino sulfonyl compounds
9. 11124485 - Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
10. 11104649 - Hydantoin containing deoxyuridine triphosphatase inhibitors
11. 11014924 - Hydantoin containing deoxyuridine triphosphatase inhibitors
12. 10858344 - Hydantoin containing deoxyuridine triphosphatase inhibitors
13. 10829457 - Nitrogen ring linked deoxyuridine triphosphatase inhibitors
14. 10577321 - Deoxyuridine triphosphatase inhibitors
15. 10570100 - Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage